Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Tuesday, February 25th. Analysts expect Guardian Pharmacy Services to post earnings of $0.20 per share for the quarter.
Guardian Pharmacy Services Trading Down 3.9 %
Shares of NYSE GRDN opened at $20.10 on Friday. Guardian Pharmacy Services has a fifty-two week low of $14.16 and a fifty-two week high of $25.74. The business has a 50 day simple moving average of $21.16.
Analyst Ratings Changes
Separately, Truist Financial boosted their target price on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, November 15th.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
- Five stocks we like better than Guardian Pharmacy Services
- How is Compound Interest Calculated?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Read Stock Charts for Beginners
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is the Shanghai Stock Exchange Composite Index?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
